Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Franklin Berger

Affiliations

  • Director at Proteostasis Therapeutics Inc. (PTI), 2019-07-01
  • Director at Kezar Life Sciences Inc. (KZR), 2019-06-27
  • Director at Atreca Inc. (BCEL), 2019-06-24
  • Director at Five Prime Therapeutics Inc (FPRX), 2019-06-12
  • Director at Tocagen Inc (TOCA), 2019-05-31
  • Director at Immune Design Corp. (IMDZ), 2019-04-04
  • Director at Seattle Genetics Inc (SGEN), 2014-02-25
  • Director at Asterias Biotherapeutics Inc. (NONE), 2013-09-28
  • Director at Biotime Inc (BTX), 2013-08-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PTI $6.75 40,000 Director 40,000 2018-10-26 Filing
KZR $15.00 50,000 Director 563,157 2018-06-25 Filing
PTI $5.00 60,000 Director 266,162 2017-12-18 Filing
IMDZ $4.58 25,000 Director 75,000 2017-10-30 Filing
IMDZ $4.26 25,000 Director 50,000 2017-10-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
IMDZ $6.55 50,000 Director 25,000 2016-12-16 Filing